Skip to content
Home/Companies/Biotech/MaaT Pharma
MP

MaaT Pharma

Biotech·France·Active·0yr hold

Maat Pharma is a healthcare company, headquartered in France.

Entry
2026
Hold
0yr
Status
Active
Est. EV
–

Who owns MaaT Pharma?

MaaT Pharma is currently owned by Seventure Partners through Health for Life Capital (2014 vintage), since 2026. Across its history, MaaT Pharma has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Seventure Partners
Most recent investor
Seventure Partners
Health for Life Capital · 2014 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods

Active
Co-held by Crédit Mutuel Equity and Seventure Partners since 2016.
Crédit Mutuel Equity
Crédit Mutuel EquityActive
2016 · present · Crédit Mutuel Equity · 1992 · Growth
MOIC
–
Seventure Partners
Seventure PartnersActive
2026 · present · Health for Life Capital · 2014 · VC
MOIC
–

More from Health for Life Capital

Other portfolio companies in the same fund.

Kainova Therapeutics
Active
HealthcareCanada· 2026
Microbiotica
Active
BiotechUK· 2026
Standing Ovation
Active
BiotechFrance· 2026
Sunrise
Active
MedTechBelgium· 2024
Cmbio –...
Active
BiotechDenmark· 2023
Cytoki
Active
BiotechDenmark· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings